Multivessel PCI guided by FFR not superior to angiography for STEMI patients: Study Medha21 July 2021 12:45 PM GMTDelhi: A fractional flow reserve (FFR) guided strategy is of no significant benefit over an angiography-guided strategy for STEMI patients undergoing...
Relevance of post-MI use of beta-blockers and MRA, reveals new study Medha20 July 2021 3:30 AM GMTUSA: The effects of beta-blocker therapy on survival after myocardial infarction (MI), when analyzed dichotomously, on (all doses) did not demonstrate ...
Crushed Prasugrel significantly Lowers Platelet Activity In Patients undergoing PCI: Study MD Bureau6 July 2021 5:00 AM GMTWhen crushed Prasugrel is administered to patients with suspected STEMI, it significantly lowered the platelet activity.
FFR guided revascularization no better than angiographic guidance in STEMI patients, FLOWER MI study dr. Abhimanyu Uppal21 May 2021 5:57 AM GMTRecent trials like COMPLETE have shown that complete revascularisation should be the norm in acute STEMI setting unless complicated by hemodynamic...
IL-6 inhibition improves myocardial salvage in post-MI setting, ASSAIL-MI trial. dr. Abhimanyu Uppal20 April 2021 1:30 AM GMTPatients with STEMI undergoing PCI who received an intravenous dose of tocilizumab, an inhibitor of the inflammatory cytokine interkleukin-6 (IL-6), pr...
Biodegradable polymer scores over durable-polymer stent for STEMI setting, BIOSTEMI study. dr. Abhimanyu Uppal7 April 2021 3:30 AM GMTPercutaneous coronary intervention (PCI) is an effective strategy to restore myocardial perfusion in patients with acute myocardial infarction....
Ticagrelor does not score over clopidogrel in thrombolysis setting, MIRTOS study dr. Abhimanyu Uppal25 Feb 2021 12:55 PM GMTContrary to the spectacular benefits seen with ticagrelor (vs. clopidogrel) in acute coronary syndrome patients undergoing percutaneous coronary...
Dissolving the dilemma: Management of Antithrombotic Therapy after Acute Coronary Syndromes dr. Abhimanyu Uppal24 Feb 2021 3:30 AM GMTThe management of antithrombotic agents for patients after an acute coronary syndrome is becoming increasingly complex. The data suggesting better drug...
Primary PCI equally effective in cancer patients with STEMI and those without cancer: Study Medha10 Feb 2021 11:45 AM GMTDelhi: Primary PCI is underused in cancer patients with active STEMI, despite it being associated with lower MACCE and in-hospital mortality just like ...
Direct admission to cath lab for primary PCI lowers death risk in STEMI patients: JAHA Medha6 Jan 2021 1:30 PM GMTIsrael: Direct admission of PPCI-treated patients with STEMI to the cath lab decreases mortality by shortening D2B and P2B intervals,...
Lesser risk of recurrent MI with prasugrel than ticagrelor in STEMI patients: Circulation Medha17 Nov 2020 8:45 AM GMTGermany: The use of ticagrelor versus prasugrel in STEMI patients undergoing primary PCI did not lead to significant differences in incidence of...
Consumption of dietary omega 3 may lower death risk after heart attack: JACC Medha28 Oct 2020 6:00 AM GMTRegularly consuming omega-3, from both animal and vegetable origins, strengthens the heart's membranes thereby helping to reduce the risk of hospital...
